Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
European High Temperature Superconductors (EHTS) was a specialist company focused on the development and manufacturing of high-temperature superconducting (HTS) materials and devices. Founded as a spin-off and later acquired by Bruker, the company's technology is critical for the production of high-field magnets used in Nuclear Magnetic Resonance (NMR) and Magnetic Resonance Imaging (MRI) systems. These systems are essential tools in life science research, drug discovery, and clinical diagnostics. Today, its operations are fully integrated into Bruker's Advanced Supercon division, supporting the next generation of ultra-high-field analytical instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European High Temperature Superconductors.